Skip to main content
OpenTrials

Clinical trial condition

Metastatic or Locally Advanced Unresectable Solid Tumors

Explore clinical trials studying Metastatic or Locally Advanced Unresectable Solid Tumors. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Metastatic or Locally Advanced Unresectable Solid Tumors trial results

Active, Not Recruiting

Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)

NCT05396833

Conditions
Metastatic or Locally Advanced Unresectable Solid Tumors, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • Augusta University - formerly Georgia Regents University Augusta, Georgia, United States
  • The University of Kansas Medical Center Research Institute, Inc. Kansas City, Kansas, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)

NCT04170153

Conditions
Metastatic or Locally Advanced Unresectable Solid Tumors, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • NEXT Oncology Austin, Texas, United States
  • Mary Crowley Cancer Research Centers Dallas, Texas, United States
  • The Methodist Hospital Research Institute Houston, Texas, United States
View all 16 locations
View Trial Details

Related conditions